Response to McIlveen et al.: Collaboration and transparency are necessary to effectively estimate substance use disorder treatment need.
作者信息
Nesoff Elizabeth D, Marziali Megan E, Martins Silvia S
机构信息
Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA.
出版信息
Addiction. 2022 Aug;117(8):2361-2362. doi: 10.1111/add.15909. Epub 2022 May 5.
Abstract
摘要
相似文献
1
Response to McIlveen et al.: Collaboration and transparency are necessary to effectively estimate substance use disorder treatment need.对麦基尔文等人的回应：合作与透明度对于有效估计物质使用障碍治疗需求是必要的。
Addiction. 2022 Aug;117(8):2361-2362. doi: 10.1111/add.15909. Epub 2022 May 5.
2
The importance of buprenorphine research in the opioid crisis.阿片类药物危机中丁丙诺啡研究的重要性。
Mol Psychiatry. 2019 May;24(5):626-632. doi: 10.1038/s41380-018-0329-5. Epub 2019 Jan 7.
3
Predictors of availability of long-acting medication for opioid use disorder.阿片类药物使用障碍长效药物供应的预测因素。
Drug Alcohol Depend. 2019 Nov 1;204:107586. doi: 10.1016/j.drugalcdep.2019.107586. Epub 2019 Sep 25.
4
Commentary on Lin et al.: Saving lives during the opioid crisis-widening the focus from opioid use disorder to polysubstance use disorder and to multimorbidity.对林等人研究的评论：在阿片类药物危机期间拯救生命——将关注点从阿片类药物使用障碍扩大到多物质使用障碍和多种疾病并存情况。
Addiction. 2021 Jan;116(1):105-106. doi: 10.1111/add.15229. Epub 2020 Sep 11.
5
Treatment of Opioid Use Disorder With Buprenorphine Among US Adolescents and Young Adults During the Early COVID-19 Pandemic.在 COVID-19 大流行早期，美国青少年和年轻成年人中用丁丙诺啡治疗阿片类药物使用障碍。
J Adolesc Health. 2022 Aug;71(2):239-241. doi: 10.1016/j.jadohealth.2022.03.015. Epub 2022 May 17.
6
Buprenorphine Treatment for Opioid Use Disorder: An Overview.阿片类物质使用障碍的丁丙诺啡治疗：概述。
CNS Drugs. 2019 Jun;33(6):567-580. doi: 10.1007/s40263-019-00637-z.
7
Commentary on Larance et al. (2020): Priorities and concerns of people who use opioids are key to scaling up XR-buprenorphine.评论 Larance 等人（2020 年）：扩大使用 XR-丁丙诺啡的重点和关注点是使用阿片类药物的人的关键。
Addiction. 2020 Jul;115(7):1306-1307. doi: 10.1111/add.15048. Epub 2020 Apr 18.
8
Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.美国退伍军人事务部的多药物使用与阿片类药物使用障碍治疗的关系。
Addiction. 2021 Jan;116(1):96-104. doi: 10.1111/add.15116. Epub 2020 Jul 7.
9
Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?新冠疫情时代阿片类物质使用障碍的药物治疗：新规定能否改变阿片类药物使用的恶性循环？
J Subst Abuse Treat. 2021 Mar;122:108196. doi: 10.1016/j.jsat.2020.108196. Epub 2020 Nov 14.
10
COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management.COVID-19：改变阿片类药物使用障碍管理中远程医疗服务提供的催化剂。
Subst Abus. 2021;42(2):205-212. doi: 10.1080/08897077.2021.1890676. Epub 2021 Mar 8.
本文引用的文献
1
State policy uptake does not require formal action: A comment on Nesoff et al.国家政策的采纳并不需要正式行动：对内索夫等人的评论
Addiction. 2022 Aug;117(8):2359-2360. doi: 10.1111/add.15886. Epub 2022 Apr 8.
2
Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019.2019 年美国需要阿片类药物治疗的青少年和成年人中，阿片类药物使用障碍药物治疗的使用情况。
JAMA Netw Open. 2022 Mar 1;5(3):e223821. doi: 10.1001/jamanetworkopen.2022.3821.
3
The estimated impact of state-level support for expanded delivery of substance use disorder treatment during the COVID-19 pandemic.估计在 COVID-19 大流行期间，州级支持扩大物质使用障碍治疗的影响。
Addiction. 2022 Jun;117(6):1781-1786. doi: 10.1111/add.15778. Epub 2021 Dec 27.
4
A comparison of office-based buprenorphine treatment outcomes in Bronx community clinics before versus during the COVID-19 pandemic.布朗克斯社区诊所新冠肺炎疫情前后基于门诊的丁丙诺啡治疗结果比较。
J Subst Abuse Treat. 2022 Apr;135:108641. doi: 10.1016/j.jsat.2021.108641. Epub 2021 Oct 27.
5
Opportunities for Research on the Treatment of Substance Use Disorders in the Context of COVID-19.2019冠状病毒病背景下物质使用障碍治疗的研究机遇
JAMA Psychiatry. 2020 Sep 1. doi: 10.1001/jamapsychiatry.2020.3177.
6
America's opioid crisis: the need for an integrated public health approach.美国的阿片类药物危机：需要采取综合公共卫生措施。
Transl Psychiatry. 2020 May 28;10(1):167. doi: 10.1038/s41398-020-0847-1.
7
Rapid Implementation of Service Delivery Changes to Mitigate COVID-19 and Maintain Access to Methadone Among Persons with and at High-Risk for HIV in an Opioid Treatment Program.在阿片类药物治疗项目中迅速实施服务提供变更，以减轻新冠疫情影响并维持艾滋病毒感染者及高危人群的美沙酮获取
AIDS Behav. 2020 Sep;24(9):2469-2472. doi: 10.1007/s10461-020-02887-1.
8
The Role of Science in Addressing the Opioid Crisis.科学在应对阿片类药物危机中的作用。
N Engl J Med. 2017 Jul 27;377(4):391-394. doi: 10.1056/NEJMsr1706626. Epub 2017 May 31.
Zotero 插件